Bath & Body Works (NYSE:BBWI) Releases Q4 2024 Earnings Guidance

Bath & Body Works (NYSE:BBWI) updated its fourth quarter 2024 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of 1.940-2.070 for the period, compared to the consensus estimate of 1.970. The company issued revenue guidance of $2.7 billion-$2.8 billion, compared to the consensus revenue estimate of $2.7 billion. Bath & Body Works also updated its Q4 guidance to $1.94-2.07 EPS.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on the company. Deutsche Bank Aktiengesellschaft upped their price target on Bath & Body Works from $51.00 to $52.00 and gave the company a “buy” rating in a research report on Tuesday. Citigroup cut their price target on Bath & Body Works from $48.00 to $35.00 and set a “neutral” rating on the stock in a report on Tuesday, August 20th. Robert W. Baird cut their price target on Bath & Body Works from $54.00 to $45.00 and set an “outperform” rating on the stock in a report on Thursday, August 29th. Piper Sandler increased their price target on Bath & Body Works from $35.00 to $36.00 and gave the stock a “neutral” rating in a report on Tuesday. Finally, UBS Group lowered their price objective on Bath & Body Works from $52.00 to $38.00 and set a “neutral” rating for the company in a research note on Thursday, August 29th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and nine have given a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $41.88.

Bath & Body Works Price Performance

Bath & Body Works stock opened at $35.23 on Wednesday. The firm has a market capitalization of $7.72 billion, a P/E ratio of 8.59, a PEG ratio of 1.14 and a beta of 1.79. Bath & Body Works has a one year low of $26.20 and a one year high of $52.99. The business has a fifty day moving average price of $30.69 and a 200-day moving average price of $35.74.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share for the quarter, beating analysts’ consensus estimates of $0.35 by $0.02. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The business had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.54 billion. Sell-side analysts expect that Bath & Body Works will post 3.18 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Friday, November 22nd will be issued a dividend of $0.20 per share. The ex-dividend date is Friday, November 22nd. This represents a $0.80 dividend on an annualized basis and a yield of 2.27%. Bath & Body Works’s dividend payout ratio is presently 19.51%.

Insider Activity at Bath & Body Works

In related news, CEO Gina Boswell purchased 6,000 shares of the company’s stock in a transaction dated Wednesday, October 9th. The shares were purchased at an average cost of $29.64 per share, with a total value of $177,840.00. Following the transaction, the chief executive officer now directly owns 242,987 shares in the company, valued at $7,202,134.68. This trade represents a 2.53 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.27% of the stock is owned by company insiders.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.